Abstract:Rare variants, comprising the vast majority of human genetic variations, are likely to have more deleterious impact in the context of human diseases compared to common variants. Here we present carrier statistic, a statistical framework to prioritize disease-related rare variants by integrating gene expression data. By quantifying the impact of rare variants on gene expression, carrier statistic can prioritize those rare variants that have large functional consequence in the patients. Through simulation studies and analyzing real multi-omics dataset, we demonstrated that carrier statistic is applicable in studies with limited sample size (a few hundreds) and achieves substantially higher sensitivity than existing rare variants association methods. Application to Alzheimer's disease reveals 16 rare variants within 15 genes with extreme carrier statistics. We also found strong excess of rare variants among the top prioritized genes in patients compared to that in healthy individuals. The carrier statistic method can be applied to various rare variant types and is adaptable to other omics data modalities, offering a powerful tool for investigating the molecular mechanisms underlying complex diseases. Existing rare variants association methods often lack statistical power when sample sizes are small. Here we propose a novel integrative statistical framework, the carrier statistic, which can leverage paired genotype and gene expression data to quantify the functional impact of rare variants and enhance detection power of rare variants responsible for disease. Extensive simulations demonstrate that carrier statistic provides well-calibrated false discovery rates, shows substantially higher sensitivity compared to existing methods, and remains robust under unbalanced case-control ratios. Through analyzing real multi-omics dataset for Alzheimer's disease, we identified 16 rare variants within 15 genes with extreme carrier statistics. We hope that the results presented in this paper can highlight the promise of the carrier statistic approach and will encourage future disease studies to collect both genotype and gene expression data for the same individuals. As multi-omics and genome sequencing data continue to expand, we anticipate that carrier statistics will be a valuable tool for elucidating the molecular mechanism underlying human complex diseases.

The Excess of Carriers in Rare Disorders Suggests a Nonpathogenic Effect for Most Variants of Uncertain Significance

Investigating the sources of variable impact of pathogenic variants in monogenic metabolic conditions

A Robust Pipeline for Ranking Carrier Frequencies of Autosomal Recessive and X-linked Mendelian Disorders.

Reproductive and cognitive effects in carriers of recessive pathogenic variants

Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies.

Major Causes of Conflicting Interpretations of Variant Pathogenicity in Rare Disease: A Systematic Analysis

The landscape of autosomal-recessive pathogenic variants in European populations reveals phenotype-specific effects

Rare and low-frequency variants in human common diseases and other complex traits

Non-coding variants are a rare cause of recessive developmental disorders in trans with coding variants

Associations with Single Rare Heterozygous NLRP7 Variants for Chinese Patients with Sporadic Gestational Trophoblastic Diseases

Interpretation of Autosomal Recessive Kidney Diseases With "Presumed Homozygous" Pathogenic Variants Should Consider Technical Pitfalls

Potentially Missed Diagnoses in Prenatal Versus Postnatal Exome Sequencing in the Lack of Informative Phenotype: Lessons Learned From a Postnatal Cohort

A Copernican Revolution of Multigenic Analysis: A Retrospective Study on Clinical Exome Sequencing in Unclear Genetic Disorders

Rare penetrant mutations confer severe risk of common diseases

Uncovering recessive alleles in rare Mendelian disorders by genome sequencing of 174 individuals with monoallelic pathogenic variants

Inconsistencies between prenatal diagnostic and genetic testing laboratories on variant validation of rare monogenic diseases

Estimating at-risk couple rates across 1000 exome sequencing data cohort for 176 genes and its importance relevance for health policies

Deviation from baseline mutation burden provides powerful and robust rare-variants association test for complex diseases

Missing genetic diversity impacts variant prioritisation for rare disorders

When genetic burden reaches threshold

Prioritizing disease-related rare variants by integrating gene expression data